乌鸦传媒

<乌鸦传媒 class="page-title">Endocrinology

General Endocrinology

<乌鸦传媒 class="page-description">

More in General Endocrinology

FDA Adds Boxed Warning to Hot Flash Drug

The warning highlights known risk of rare but serious liver injury associated with fezolinetant

Dec 17, 2024
FDA WARNING fezolinetant (Veozah) over a photo of the product.
Endocrinologist Deserts; U.S. Obesity Declines; New Obesity Definition Coming Soon

News and commentary from the endocrinology world

Dec 17, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
FDA Approves First Drug for Classic Congenital Adrenal Hyperplasia in 70 Years

Crinecerfont reduces excessive adrenal androgen production, lowering glucocorticoid dose

Dec 16, 2024
FDA APPROVED crinecerfont (Crenessity) over a computer rendering of a transparent body with the adrenal glands highlighted.
The FDA Hasn't Inspected This Drug Factory After 7 Recalls for the Same Flaw

With a potentially deadly recall, case highlights shortcomings in overseas drug manufacturing

Dec 15, 2024
A photo of the Glenmark logo on a facility occupied by Glenmark Pharmaceuticals in Mahwah, New Jersey.
Should Pharmaceutical Companies Sell Weight-Loss Drugs Directly to Consumers?

Physicians, policymakers raise questions about LillyDirect connecting patients with telehealth

Dec 06, 2024
A photo of a woman holding a smartphone which is displaying the Eli Lilly logo.
FDA Panned at Senate Hearing for Failure to Address Diabetes, Obesity Epidemics

Agency has failed to hold food manufacturers accountable, said Sen. Bernie Sanders

Dec 05, 2024
A screenshot of Bernie Sanders speaking during this hearing.
ADA Advises Against Compounded GLP-1s; Growth Hormone Therapy Guide; T1D Outcomes Up

News and commentary from the endocrinology world

Dec 03, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
Biden Proposes Coverage of Obesity Drugs in Medicare, Medicaid

Federal government would pick up about three-fourths of the cost for Medicaid coverage

Nov 26, 2024
Semaglutide (GLP-1) weight-loss drug Wegovy
Thyroid Drug & Bone Loss; GLP-1s' Renal Benefit; Menopause Musculoskeletal Syndrome

News and commentary from the endocrinology world

Nov 26, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
Opinion
GLP-1 Use Prior to Surgery: Analyzing the Updated Guidance

Balancing aspiration risk with the consequences of medication discontinuation

Nov 20, 2024
A photo of an injection pen.
Doc Killed After Presentation; Bird Flu Mutations Worrying; Americans Snub COVID Vax

Health news and commentary gathered by 乌鸦传媒 staff

Nov 20, 2024
Morning Break over illustration of a syringe, Covid virus, and DNA helix over a photo of green vegetation.
75% of Adults Overweight or Obese; Global Diabetes Tx Lacking; Hidden Bone Data?

News and commentary from the endocrinology world

Nov 19, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
Oral Drug Safe, Effective in Kids With Achondroplasia

No adverse events resulted in treatment discontinuation

Nov 18, 2024
A photo of a group of boys affected by achondroplasia.
Tirzepatide Officially Puts GLP-1 Meds on the Map for Heart Failure Benefit

SUMMIT trial able to show clinical benefit beyond quality-of-life improvement

Nov 16, 2024
AHA over a photo of McCormick Place Convention Center in Chicago, IL.
More in General Endocrinology

0.50 CME Credits
Adjuvant Endocrine Therapy in HR+ Breast Cancer: Enhancing Quality Care and Patient Outcomes

0.75 CME Credits
Navigating Endocrine Resistance: Latest Strategies in HR+/HER2- Breast Cancer Care

0.25 CME Credits
Applying the Latest Evidence to Overcome Endocrine Resistance in HR+/HER2- Breast Cancer

0.50 CME Credits
Examining the Pathophysiology, Burden, and Evolving Treatment Landscape of Acromegaly

0.50 CME Credits
Enhancing Acromegaly Care Through Integration of the Latest Clinical Evidence and Patient-Centered Management

1.00 CME Credits
Navigating Cardiovascular Risk: The Critical Role of Lipoprotein(a) Screening and Treatment

0.50 CME Credits
Beyond Statin Therapy: Evidence-Based Strategies and Advanced Therapeutic Approaches to Hyperlipidemia Management

0.75 CME Credits
Aligning Clinical Practices With the Latest Evidence in Management of Comorbidities and Complications in People With Cystic Fibrosis